These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 35647371)

  • 1. A Comparative Study on Bacterial Co-Infections and Prevalence of Multidrug Resistant Organisms among Patients in COVID and Non-COVID Intensive Care Units.
    Sathyakamala R; Peace AR; Shanmugam P
    J Prev Med Hyg; 2022 Mar; 63(1):E19-E26. PubMed ID: 35647371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
    Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
    Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial co-infections in cancer patients with COVID-19: predictors and antimicrobial resistance trends.
    Abdel-Hamid RM; Bayoumi A; Abdellateif MS; Nooh HA; Refaat L; Kandeel EZ; Hassan SS
    J Infect Dev Ctries; 2024 Aug; 18(8):1185-1195. PubMed ID: 39288390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
    Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
    F1000Res; 2022; 11():30. PubMed ID: 35811795
    [No Abstract]   [Full Text] [Related]  

  • 5. Multidrug resistant bacterial infections in severely ill COVID-19 patients admitted in a national referral and teaching hospital, Kenya.
    Mutua JM; Njeru JM; Musyoki AM
    BMC Infect Dis; 2022 Nov; 22(1):877. PubMed ID: 36418990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary bacterial infections of the respiratory tract in COVID-19 patients.
    Mumcuoğlu İ; Çağlar H; Erdem D; Aypak A; Gün P; Kurşun Ş; Çakır EY; Aydoğan S; Kırca F; Dinç B
    J Infect Dev Ctries; 2022 Jul; 16(7):1131-1137. PubMed ID: 35905017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis.
    Li J; Wang J; Yang Y; Cai P; Cao J; Cai X; Zhang Y
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):153. PubMed ID: 32962731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial infections and outcomes of inpatients with COVID-19 in the intensive care unit during the delta-dominant phase: the worst wave of pandemic in Iran.
    Akbari M; Dehghani Y; Shirzadi M; Pourajam S; Hosseinzadeh M; Sajadi M; Alenaseri M; Siavash M; Jafari L; Solgi H
    Front Public Health; 2024; 12():1411314. PubMed ID: 39314786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased antimicrobial resistance during the COVID-19 pandemic.
    Lai CC; Chen SY; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2021 Apr; 57(4):106324. PubMed ID: 33746045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-infection in critically ill patients with COVID-19: an observational cohort study from England.
    Baskaran V; Lawrence H; Lansbury LE; Webb K; Safavi S; Zainuddin NI; Huq T; Eggleston C; Ellis J; Thakker C; Charles B; Boyd S; Williams T; Phillips C; Redmore E; Platt S; Hamilton E; Barr A; Venyo L; Wilson P; Bewick T; Daniel P; Dark P; Jeans AR; McCanny J; Edgeworth JD; Llewelyn MJ; Schmid ML; McKeever TM; Beed M; Lim WS
    J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33861190
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).
    Kariyawasam RM; Julien DA; Jelinski DC; Larose SL; Rennert-May E; Conly JM; Dingle TC; Chen JZ; Tyrrell GJ; Ronksley PE; Barkema HW
    Antimicrob Resist Infect Control; 2022 Mar; 11(1):45. PubMed ID: 35255988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review.
    Segala FV; Bavaro DF; Di Gennaro F; Salvati F; Marotta C; Saracino A; Murri R; Fantoni M
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream Coinfections and Antimicrobial Resistance in Hospitalized COVID-19 Patients: A Single-center Retrospective Study.
    Tsai YH; Hou TC; Liu PY; Chen CJ; Wang JM
    In Vivo; 2024; 38(4):1965-1972. PubMed ID: 38936952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bacterial coinfections and susceptible antibiotic profiles in hospitalized COVID-19 patients in Koya district, Iraq.
    Omar SZ; Mustafa SK
    J Infect Dev Ctries; 2023 Nov; 17(11):1537-1543. PubMed ID: 38064399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.
    Wu HY; Chang PH; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Lee SS;
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):985-992. PubMed ID: 36243668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study.
    Agaba P; Tumukunde J; Tindimwebwa JVB; Kwizera A
    BMC Res Notes; 2017 Jul; 10(1):349. PubMed ID: 28754148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.
    Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M
    Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU.
    Sharifipour E; Shams S; Esmkhani M; Khodadadi J; Fotouhi-Ardakani R; Koohpaei A; Doosti Z; Ej Golzari S
    BMC Infect Dis; 2020 Sep; 20(1):646. PubMed ID: 32873235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.